Zaozhuang Municipal Hospital

Registry for the Management of Helicobacter Pylori Infection in Shandong Province

Role: collaborator

Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis

Role: collaborator

Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology

Role: collaborator

Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

Role: collaborator

Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

Role: collaborator

7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori

Role: collaborator

Effect of Predictive Model on Double-Balloon Enteroscopy

Role: collaborator

P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Role: collaborator

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Role: collaborator

DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis

Role: collaborator

Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention

Role: collaborator

Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication

Role: collaborator

Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori

Role: collaborator

Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

Role: collaborator

Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori（SHARE2302)

Role: collaborator